VH
Venrock Healthcare Capital Partners
Palo Alto, California, United StatesFounded 2009
Venrock Healthcare Capital Partners focuses on long-term investment opportunities in small capitalization public companies and late-stage private companies within the healthcare and life sciences industry, with a particular emphasis on biopharmaceuticals. They also target early-stage companies in healthcare and technology, seeking disruptive ideas in areas like digital health and biotech, often leading seed and Series A funding rounds.
Portfolio
4
Fund Size
—
Top Stage
Series C
Last 12 Mo
1
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Surrozen, Inc. | Series D | $175M | Mar 2025 |
| Averto Medical Inc | Series A | $30.5M | May 2024 |
| Athira Pharma, Inc. | Series B | $85M | Jun 2020 |
| Jade Biosciences | Series C | $95M | — |
Top Co-Investors
Franklin Templeton2 shared
RTW Investments2 shared
Braidwell LP2 shared
LifeSci Venture Partners2 shared
Frazier Life Sciences1 shared
Versant Ventures1 shared
Deep Track Capital1 shared
Cormorant Asset Management1 shared
Perceptive Advisors1 shared
Viking Global Investors1 shared
Rock Springs Capital1 shared
Surveyor Capital1 shared
Logos Capital1 shared
Janus Henderson Investors1 shared
Sofinnova Partners1 shared
Avidity Partners1 shared
The Column Group1 shared
Access Biotechnology1 shared
RA Capital Management1 shared
Vivo Capital1 shared
Last updated: 3 March 2026